Triple-negative breast cancer (TNBC) is defined by the absence of expression of the estrogen receptor (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and accounts for approximately 10-15% of all breast cancers. This evidence concerns the gene PGR and breast cancer.